Effects of the Indian National Health Insurance Scheme (PM-JAY) on Hospitalizations, Out-of-pocket Expenditures and Catastrophic Expenditures
Divya Parmar, Christoph Strupat, Swati Srivastava, Stephan Brenner, Diletta Parisi, Susanne Ziegler, Rupak Neogi, Caitlin Walsh, Manuela De Allegri
HEALTH SYSTEMS & REFORM (2023)
Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore
Junxing Chay, Joshua Yi Min Tung, Rebecca Jade Su, Edwin Jonathan Aslim, Callix Wong, Georgia Swan, Wei Jin Chua, Henry Sun Sien Ho, Eric Andrew Finkelstein
JOURNAL OF MEDICAL ECONOMICS (2023)
Healthcare costs among patients with newly diagnosed helicobacter pylori infection in the United States: a linked claims-EHR study
Shailja Shah, Katherine Cappell, Robert Sedgley, Corey Pelletier, Rinu Jacob, Machaon Bonafede, Rena Yadlapati
JOURNAL OF MEDICAL ECONOMICS (2023)
Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study
Yan Wang, Weihua Gao, Xu Han, Jenny Jiang, Belinda Sandler, Xiaoyan Li, Carla Zema
JOURNAL OF MEDICAL ECONOMICS (2023)
Cost-effectiveness of Left Atrial Appendage Closure with WATCHMAN device for non-valvular atrial fibrillation patients in Japan. Are the policy implications big in Japan?
Panagiotis Petrou
JOURNAL OF MEDICAL ECONOMICS (2023)
Health care resource utilization in 3L+patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinib
Jorge E. Cortes, Delphine Rea, Michael J. Mauro, Diana Tran, Pearl Wang, Kejal Jadhav, Aurore Yocolly, Koji Sasaki
JOURNAL OF MEDICAL ECONOMICS (2023)
Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide
Sasha Berry, Barrie Chubb, Annabel Acs, Edel Falla, Akanksha Verma, Samuel J. P. Malkin, Barnaby Hunt, Andrew J. Palmer
JOURNAL OF MEDICAL ECONOMICS (2023)
Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
Stephane Alexandre Regnier, Xin Ying Lee
JOURNAL OF MEDICAL ECONOMICS (2023)
Impact of information and deliberation on the consistency of preferences for prioritization in health care - evidence from discrete choice experiments undertaken alongside citizens' juries
Jennifer A. Whitty, Peter Littlejohns, Julie Ratcliffe, Kylie Rixon, Andrew Wilson, Elizabeth Kendall, Paul Burton, Kalipso Chalkidou, Paul A. Scuffham
JOURNAL OF MEDICAL ECONOMICS (2023)
Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand
Warittakorn Kategeaw, Nontaya Nakkam, Sasisopin Kiertiburanakul, Chonlaphat Sukasem, Wichittra Tassaneeyakul, Nathorn Chaiyakunapruk
JOURNAL OF MEDICAL ECONOMICS (2023)
Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes (vol 26, pg 935, 2023)
P. Rossing, F. Groehl, P. Mernagh, K. Folkerts, A. Garreta Rufas, J. Harris, K. Meredith, M. Carter, O. Akerborg, C. Wanner, F. D. Richard Hobbs
JOURNAL OF MEDICAL ECONOMICS (2023)
Economic burden of respiratory syncytial virus infection in adults: a systematic literature review
Mei Grace, Ann Colosia, Sorrel Wolowacz, Catherine Panozzo, Parinaz Ghaswalla
JOURNAL OF MEDICAL ECONOMICS (2023)
Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs
Aaron T. T. Gerds, Jingbo Yu, Anne Shah, Ann Xi, Shambhavi Kumar, Robyn Scherber, Shreekant Parasuraman
JOURNAL OF MEDICAL ECONOMICS (2023)
Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States
Pengxiang Li, Carmela Benson, Zhi Geng, Sanghyuk Seo, Charmi Patel, Jalpa A. A. Doshi
JOURNAL OF MEDICAL ECONOMICS (2023)
Implementation of technology in healthcare entities - barriers and success factors
Teresa Pakulska, Urszula Religioni
JOURNAL OF MEDICAL ECONOMICS (2023)
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland
Andrea Favre-Bulle, Goran Bencina, Shujing Zhang, Ruixuan Jiang, Daniel Andritschke, Arjun Bhadhuri
JOURNAL OF MEDICAL ECONOMICS (2023)
Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States
Wei Gao, Arash Mostaghimi, Kavita Gandhi, Nicolae Done, Markqayne Ray, James Signorovitch, Elyse Swallow, Christopher Carley, Travis Wang, Vanja Sikirica
JOURNAL OF MEDICAL ECONOMICS (2023)
Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims-based retrospective cohort study
Tu My To, Jamie T. Ta, Anisha M. Patel, Stella Arndorfer, Ibrahim M. Abbass, Rita Gandhy
JOURNAL OF MEDICAL ECONOMICS (2023)
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS
Paulos Gebrehiwet, Lisa Meng, Stacy A. Rudnicki, Phil Sarocco, Jenny Wei, Andrew A. Wolff, Michael Butzner, Adriano Chio, Jinsy A. Andrews, Angela Genge, Dyfrig A. Hughes, Carlayne E. Jackson, Noah Lechtzin, Timothy M. Miller, Jeremy M. Shefner
JOURNAL OF MEDICAL ECONOMICS (2023)
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States
Manuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, Timothy. L. L. Wiemken, Jingyan Yang, Benjamin Yarnoff
JOURNAL OF MEDICAL ECONOMICS (2023)